IZKF-N12 Autoimmuntherap.uT-Zell(341/M3): T cell plasticity and functionality under conventional autoimmune disease therapies
FAU own research funding: EFI / IZKF / EAM ...
Start date : 01.04.2025
End date : 31.03.2027
Project details
Scientific Abstract
The proposed project will investigate the effect of common therapies such as hydroxychloroquine, tocilizumab, mycophenolate mofetil or rituximab in systemic lupus and systemic sclerosis patients. Closing a major gap in our knowledge of how distinct therapies influence T cell differentiation, metabolic reprogramming, subsets distribution and effector functions; this study will guide the improvement of disease management to favour immune competence.
Involved:
Contributing FAU Organisations:
Interdisziplinäres Zentrum für Klinische Forschung (IZKF)
Professur für Modulation von Immunantworten
